Portfolio company
CardiNor
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops secretoneurin blood assays for laboratories and researchers to assess risk in patients with cardiovascular disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ACS Biomarker
This company provides biomarker discovery and validation services for cardiovascular disease diagnostics to academic research groups and pharmaceutical industry partners.
CardioDx
This company produces a genomic blood test for clinicians to assess the likelihood of obstructive coronary artery disease in symptomatic, non-diabetic patients.
LipoScience
This company develops nuclear magnetic resonance diagnostic tests and clinical analysers for laboratories and physicians to manage patient cardiovascular and metabolic disease risks.
Cardisio
This company develops non-invasive screening technology using artificial intelligence and vectorcardiography to detect heart diseases for healthcare professionals and clinical practices.
CardioSignal
This company develops smartphone-based software for the early detection of heart diseases, serving primary care doctors and their patients.
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
Rapidscan
This company develops biopharmaceutical stress agents used for cardiovascular disease diagnosis in healthcare settings.
Cytox
This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.